Menu
THELOCATIONOFTHE > HOME >News >News 2016-2018

The Monitoring and Management of Chills and the Treatment of Analgesia and Sedation in TTM

2019.03.18 / Monday


The Monitoring and Management of Chills and the Treatment of Analgesia and Sedation in TTM 


anesthesia chills


Perioperative anesthesia and incorrect target temperature managementTTM may cause postoperative chills, which will directly affect the survival rate of patients.

Correct target temperature management TTM can significantly reduce the probability of postoperative chills. For patients with existing chills, it is recommended to standardize the evaluation of chills. Based on accuracy and reliability of scoring, BSASbedside shiver assessment scale is recommended as a clinical evaluation tool for chills.

 

Clinicians should rely on the evaluation results to develop a detailed treatment plan in time.

For patients who have received intravascular hypothermia therapy in the early stage, the most recommended anesthesia is non-drug therapy.

The key of treatment is to use the body surface insulation device to help patients recover their body temperature, and monitor the temperature change of patients in real time through the medical temperature probe, so as to prevent the hyperthermia or hypothermia caused by the later treatment.

 

For away, which does not have a satisfactory effect of using the body surface insulation device alone to control chills, it can be considered to combine with medication.

It is recommended to give priority to the use of non-sedative drugs (such as magnesium, paracetamol, etc.).

If chills are still uncontrollable, consider using narcotic analgesics and sedatives.

 

 

The analgesic and sedative treatments in target temperature management can be referred to as follows:

 

For the target body temperature less than 36 in severe cases, recommended for soothing calm treatment.

The use of analgesic and sedative drugs may or may not be appropriate for severe patients who maintain a normal body temperature.

The use of muscle relaxants in hypothermic therapy is obviously controversial, and long-term use is not recommended.


skype